SB
ACAD icon

Suntrust Banks’s Acadia Pharmaceuticals ACAD Stock Holding History

Suntrust Banks’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,400
Closed -$226K – 1257
2015
Q2 		$226K Buy
+5,400
New +$209K ﹤0.01% 1125
2014
Q3 		– Sell
-10,527
Closed -$236K – 1372
2014
Q2 		$236K Sell
10,527
-1,003
-9% -$20.9K ﹤0.01% 1304
2014
Q1 		$280K Buy
11,530
+92
+0.8% +$2.33K ﹤0.01% 1618
2013
Q4 		$284K Buy
11,438
+35
+0.3% +$826 ﹤0.01% 1543
2013
Q3 		$312K Buy
+11,403
New +$238K ﹤0.01% 1465

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return